Loading clinical trials...
Loading clinical trials...
The study was designed to explore the clinical feasibility of XTR003, a PET myocardial fatty-acid tracer, for the detection of viable myocardium in patients with ischemic heart disease (IHD).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sinotau Pharmaceutical Group
NCT07373353 · Ischemic Heart Disease (IHD)
NCT07351825 · Ischemic Heart Disease (IHD), Myocardial Infarction (MI)
NCT07186582 · Coronary Artery Disease, Ischemic Heart Disease (IHD), and more
TEDA International Cardiovascular Hospital
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions